EULAV Asset Management

Q2 2022 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2022
Date filed
7/22/2022
Form type
13F-HR
Num holdings
202
Total value ($000)
$2,423,366
Net value change ($000)
-936,524 (-27.9%)
New positions
13
Sold out positions
28
Turnover %
7.8%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/10/2022 Next filing: 11/4/2022 SEC filing

Snapshot: Change Analysis

Compared to Q1 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
AMD 9,180 NEW
BKNG 8,397 NEW
DVN 7,164 NEW
LULU 6,815 NEW
MRSH 6,645 NEW
ZTS 4,469 NEW
GNRC 4,422 NEW
EL 4,329 NEW
NKE 4,092 NEW
DKNG 3,734 NEW
Top Reduces (Value $000, Stocks/ETFs)
MA -45,334 -74.2%
ROP -36,741 -46.4%
SPGI -23,939 -30.4%
TDY -23,626 -27.5%
DHR -23,475 -27.8%
IDXX -22,847 -51.6%
TMO -22,008 -28.2%
Biohaven Pharmaceutical Holding Co Ltd. -21,935 -100.0%
CRM -21,544 -34.6%
WCN -19,088 -54.3%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type